Regenerative biotechnology
CTM Biodent Gingiva
Injectable solution with mesenchymal stem cells for regeneration of affected gingival tissue.
Product based on placenta-derived mesenchymal stem cells that promote regeneration of gingival tissue and restoration of damaged periodontal structures.
Composition
Placenta-derived mesenchymal stem cells.
Pharmaceutical form
Injectable solution.
Monovette with 4 ml.
Plastic monovette with 1 ml, 5 million cells.
Therapeutic Properties
Promotes gingival regeneration through the release of trophic factors with antiapoptotic, antifibrotic, angiogenic, and mitotic effects, in addition to local immunological modulation.
- Regeneration of gingival tissue
- Modulation of the immune system
- Local angiogenic stimulation
- Reduction of periodontal inflammation
- Repair of the periodontal ligament
- Regeneration of root cementum
- Regeneration of alveolar bone
- Improvement of periodontal condition
Mechanism of action & Clinical data
Release of trophic factors and extracellular vesicles that modulate inflammation, immunity, and promote regeneration of periodontal tissues.
Indications
Regeneration of gingival tissue in cases of loss or recession due to periodontal disease, trauma, or surgical interventions.
Administration
Intrafilamentary by injection into free or marginal gingiva; application by a trained professional, at intervals of 4 to 6 weeks.
Contraindications
Sensitivity to formula components and diagnosis of neoplasia.
Storage
Refrigerate between 2 and 8 ℃, protect from light, do not freeze, administer within a maximum of 24 hours after receipt.
